Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02860000 |
|---|---|
| Brief Title: | Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer |
| First Submitted : | August 4, 2016 |
| First Submitted that Met QC Criteria : | August 4, 2016 |
| First Posted : | August 9, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 16, 2024 |
| Last Update Posted : | January 18, 2024 |